[1] Singal AK,Bataller R,Ahn J,et al.ACG Clinical Guideline: Alcoholic liver disease. Am J Gastroenterol,2018,113:175-194.
[2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南(2018年更新版). 实用肝脏病杂志,2018,21(2):170-176.
[3] Jonas DE,Amick HR,Feltner C,et al.Pharmacotherapy for adults with alcohol use disorders in outpatient settings:a systematic review and Meta-analysis. J Am Med Ass,2014,311(18):1889-1900.
[4] Mcclain C,Vatsalya V,Cave M.Role of zinc in the development/progression of alcoholic liver disease. Curr Treat Opt Gastroenterol,2017,15(2):285-295.
[5] Vatsalya V,Kong M,Cave M C,et al.Association of serum zinc with markers of liver injury in very heavy drinking alcohol-dependent patients. J Nutrit Biochem,2018,59:49-55.
[6] Song M,Mohammad MK,Falkner K,et al.Zinc sulfate for alcoholic cirrhosis(ZAC) clinical trial-interim analysis of clinical parameters,intestinal permeability and liver fibrosis biomarker. Hepatology,2014,60(S1):787A.
[7] Hosui A,Hiramatsu N.Oral zinc supplementation improves liver function and decreases the risk of hepatocellular carcinoma development. Hepatology,2016,64(S1):92A.
[8] Kizilgul M,Ozcelik O,Delibasi T.Bone health and vitamin D status in alcoholic liver disease. Indian J Gastroenterol,2016,35(4):1-7.
[9] Savic Z,Damjanov D,Curic N,et al.Vitamin D status,bone metabolism and bone mass in patients with alcoholic liver cirrhosis. Bratisl Lek Listy,2014,115:573-578.
[10] Zeljka Savic T,Vracaric V,Milic N,et al. Vitamin D supplementation in patients with alcoholic liver cirrhosis:a prospective study. Minerva Med,2018,[ahead of print].
[11] Chen P,Torralba M,Tan J,et al.Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice.Gastroenterology,2015,148(1),203-214.
[12] Zhong W,Li Q,Xie G,et al.Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. Am J Physiol Gastrointest Liver Physiol,2013,305(12):G919-G932.
[13] Kirpich IA,Feng W,Wang Y,et al.The type of dietary fat modulates intestinal tight junction integrity,gut permeability,and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res,2012,36(5):835-846.
[14] Tedesco L,Corsetti G,Ruocco C,et al.A specific amino acid formula prevents alcoholic liver disease in rodents. Am J Physiol Gastrointest Liver Physiol,2018,314(5):G566-G582.
[15] Szabo G,Bala S.Alcoholic liver disease and the gut-liver axis. World J Gastroenterol,2010,16(11):1321-1329.
[16] Uesugi T,Froh M,Arteel GE,et al.Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology,2001,34(1):101-108.
[17] Llorente C,Jepsen P,Inamine T,et al.Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature Communicat,2017,8:837.
[18] Koga H,Tamiya Y,Mitsuyama K,et al.Probiotics promote rapid-
turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis. Hepatol Int,2013,7(2):767-774.
[19] Bang CS,Hong SH,Suk KT,et al.Effects of Korean red ginseng(Panax ginseng),urushiol(Rhusvernicifera stokes),and probiotics(Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease. J Ginseng Res,2014,38(3):167-172.
[20] Peng C,Starkel P,Turner JR,et al.Dysbiosis-induced intestinal inflammation activates TNFRI and mediates alcoholic liver disease in mice. Hepatology,2014,61(3):883.
[21] Hartmann P,Hochrath K,Horvath A,et al.Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology,2018,67(6):2150-2166.
[22] Jasmohan S,Bajaj MD,FAASLD,et al. Gut-liver axis alterations in alcoholic liver disease:Are bile acids the Answer Hepatology,2018,67(6):2074-2075.
[23] Madsen BS,Trebicka J,Thiele M,et al.Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease:study protocol for a randomized controlled trial. Trials,2018,19(1):143.
[24] Xu MJ,Zhou Z,Parker R,et al.Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Therapeut,2017,180:77-89.
[25] Yang AM,Inamine T,Hochrath K,et al.Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest,2017,127(7):2829-2841.
[26] Shao T,Zhao C,Li F,et al. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J Hepatol,2018,[ahead of print].
[27] Adachi Y,Bradford BU,Gao W,et al.Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology,1994,20(2):453-460.
[28] Yoshiya S,Shirabe K,Imai D,et al.Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol,2015,50(5):573-582.
[29] Singh V,Sharma AK,Narasimhan RL,et al.Granulocyte colony-
stimulating factor in severe alcoholic hepatitis:A randomized pilot study. Am J Gastroenterol,2014,109(9):1417-1423.
[30] Singh V,Keisham A,Bhalla A,et al. Efficacy of granulocyte colony-stimulating factor and N-acetylcysteine therapies in patients with severe alcoholic hepatitis. Clin Gastroenterol Hepatol,2018,[ahead of print].
[31] Riva A,Patel V,Kurioka A,et al.Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease. Gut,2018,67(5):918-930.
[32] Gao B,Ma J,Xiang X. MAIT cells:a novel therapeutic target for alcoholic liver disease Gut,2018,67(5):784-786.
[33] Gao B,Tsukamoto H. Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe Gastroenterology,2016,150(8):1704-1709.
[34] Tilg H,Moschen AR,Szabo G.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology,2016,12(3):955-965.
[35] Petrasek J,Bala S,Csak T,et al.IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest,2012,122(10):3476-3489.
[36] Saikia P,Bellos D,Mcmullen MR,et al.miR181b-3p and its target importin α5 regulate TLR4 signaling in Kupffer cells and liver injury in mice in response to ethanol. Hepatology,2017,66(2):602-615.
[37] Li M,He Y,Zhou Z,et al.MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils. Gut,2017,66(4):705-715.
[38] Wang S,Ding WX.A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury. Gut,2017,66(4):565-566.
[39] Blaya D,Coll M,Rodrigo-Torres D,et al.Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut,2016,65(9):1535-1545.
[40] He Y,Gao B.A small specific-sized hyaluronic acid ameliorates alcoholic liver disease by targeting a small RNA:New hope for therapy Hepatology,2017,66(2):321-323.
[41] Xiao J,Zhang R,Huang F,et al.Lychee (Litchi chinensis Sonn) pulp phenolic extract confers a protective activity against alcoholic liver disease in mice by alleviating mitochondrial dysfunction. J Agricult Food Chem,2017,65(24):5000-5009. |
